L Chesnel Selected Research

CB-183,315

12/2017	Surotomycin versus vancomycin in adults with Clostridium difficile infection: primary clinical outcomes from the second pivotal, randomized, double-blind, Phase 3 trial.
9/2014	Efficacy of surotomycin in an in vitro gut model of Clostridium difficile infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Chesnel Research Topics

Disease

3	Clostridium Infections 01/2018 - 09/2014
1	Infections 01/2018

Drug/Important Bio-Agent (IBA)

2	CB-183,315IBA 12/2017 - 09/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	Vancomycin FDA LinkGeneric 12/2017
1	Clindamycin (Cleocin)FDA LinkGeneric 09/2014
1	LipopeptidesIBA 09/2014